We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
News

TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services

TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services
News

TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "TriLink BioTechnologies, Inc. Relaunches Oligonucleotide Radiolabeling Services"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

“We’ve learned that no other suppliers have exactly our expertise in this area. We felt discontinuing this service left our customers with no viable option for highly modified radioactive oligonucleotides, and therefore we had to rescind our decision,” said TriLink CEO, Dr. Richard Hogrefe.

TriLink leads the industry in unique modified nucleic acids and mid-scale oligonucleotide synthesis. High quality products and technical support are its key strengths. TriLink operates a fully GMP laboratory with a QSR environment. TriLink has over 13 years experience synthesizing radiolabeled DNA and RNA oligonucleotides. 35S and 3H labeling of both phosphodiester and phosphorothioate oligonucleotides are offered, as well as additional modifications.

Advertisement